A Ahr

Summary

Affiliation: Frankfurt am Main
Country: Germany

Publications

  1. ncbi T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
    Achim Rody
    Department of Obstetrics and Gynecology, JW Goethe University, Theodor Stern Kai 7, Frankfurt, Germany
    Breast Cancer Res 11:R15. 2009
  2. ncbi Cross-reactive staining of normal bone-marrow cells by monoclonal antibody 2E11
    A Ahr
    Department of Obstetrics and Gynecology, J W Goethe University, Frankfurt, Germany
    Int J Cancer 84:502-5. 1999
  3. ncbi Molecular classification of breast cancer patients by gene expression profiling
    A Ahr
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    J Pathol 195:312-20. 2001
  4. ncbi [Risk factors for recurrence of vulvar intraepithelial neoplasia III (VIN III)]
    A Ahr
    Gynäkologische Praxis am Ziegelturm, Gelnhausen
    Zentralbl Gynakol 128:347-51. 2006
  5. ncbi [Cervical cancer screening of HIV-positive women: is a prolongation of the screening interval meaningful?]
    A Ahr
    Gynäkologische Praxis am Ziegelturm, Gelnhausen
    Zentralbl Gynakol 128:242-5. 2006
  6. ncbi [Management of HIV-positive pregnancies -- results from a retrospective study]
    A Ahr
    Zentrum für Frauenheilkunde der J W G Universität Frankfurt M
    Zentralbl Gynakol 127:242-7. 2005
  7. ncbi [Identification of preeclampsia by cDNA-gene expression profiling in human placentas and serum -- a pilot study]
    A Ahr
    Gynäkologische Praxis am Ziegelturm, Am Ziegelturm 4, 63571 Gelnhausen
    Zentralbl Gynakol 128:138-42. 2006
  8. ncbi Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Breast 16:86-93. 2007
  9. ncbi Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer
    A Rody
    Department of Obstetrics and Gynecology, JW Goethe University, Frankfurt, Germany
    Breast Cancer Res Treat 113:457-66. 2009
  10. ncbi Prognostic impact of thymidine phosphorylase expression in breast cancer--comparison of microarray and immunohistochemical data
    E Ruckhäberle
    Department of Obstetrics and Gynecology, Goethe University, Frankfurt M, Germany
    Eur J Cancer 46:549-57. 2010

Detail Information

Publications18

  1. ncbi T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
    Achim Rody
    Department of Obstetrics and Gynecology, JW Goethe University, Theodor Stern Kai 7, Frankfurt, Germany
    Breast Cancer Res 11:R15. 2009
    ..However, specific lymphocytes might also promote tumor progression by shifting the cytokine milieu in the tumor...
  2. ncbi Cross-reactive staining of normal bone-marrow cells by monoclonal antibody 2E11
    A Ahr
    Department of Obstetrics and Gynecology, J W Goethe University, Frankfurt, Germany
    Int J Cancer 84:502-5. 1999
    ..As long as there is no antibody available which is highly specific for epithelial cells, detection of microdisseminated tumor cells in bone marrow by antigen-antibody reaction should be verified morphological criteria...
  3. ncbi Molecular classification of breast cancer patients by gene expression profiling
    A Ahr
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    J Pathol 195:312-20. 2001
    ....
  4. ncbi [Risk factors for recurrence of vulvar intraepithelial neoplasia III (VIN III)]
    A Ahr
    Gynäkologische Praxis am Ziegelturm, Gelnhausen
    Zentralbl Gynakol 128:347-51. 2006
    ..The therapy of VIN is the in toto resection. Still some patients develop VIN recurrence. The aim of this retrospective study is the identification of risk factors for VIN recurrence...
  5. ncbi [Cervical cancer screening of HIV-positive women: is a prolongation of the screening interval meaningful?]
    A Ahr
    Gynäkologische Praxis am Ziegelturm, Gelnhausen
    Zentralbl Gynakol 128:242-5. 2006
    ..Cervical cancer screening guidelines stated recently that the screening interval of healthy women can be extended up to 3 years. Can those recommendations be applied for high risk populations?..
  6. ncbi [Management of HIV-positive pregnancies -- results from a retrospective study]
    A Ahr
    Zentrum für Frauenheilkunde der J W G Universität Frankfurt M
    Zentralbl Gynakol 127:242-7. 2005
    ..The management of HIV-positive pregnancies was investigated in conjunction to pre-, peri and postpartal complications and the HIV transmission rate...
  7. ncbi [Identification of preeclampsia by cDNA-gene expression profiling in human placentas and serum -- a pilot study]
    A Ahr
    Gynäkologische Praxis am Ziegelturm, Am Ziegelturm 4, 63571 Gelnhausen
    Zentralbl Gynakol 128:138-42. 2006
    ..With a new approach, the cDNA-Array analysis, human placentas and blood from preeclamptic and healthy pregnant women were examined for differentially expressed genes to find typical genes expression profiles...
  8. ncbi Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Breast 16:86-93. 2007
    ..017) as well as overall response (P=0.037) and clinical complete response (cCR, P=0.050). In contrast, for both TOPO IIalpha and MAPT no correlation with pCR was observed in our sample group...
  9. ncbi Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer
    A Rody
    Department of Obstetrics and Gynecology, JW Goethe University, Frankfurt, Germany
    Breast Cancer Res Treat 113:457-66. 2009
    ..There is growing evidence that TOP2A protein expression is a strong prognostic and TOP2A gene amplification might be a predictive marker (particularly for the use of anthracyclines)...
  10. ncbi Prognostic impact of thymidine phosphorylase expression in breast cancer--comparison of microarray and immunohistochemical data
    E Ruckhäberle
    Department of Obstetrics and Gynecology, Goethe University, Frankfurt M, Germany
    Eur J Cancer 46:549-57. 2010
    ..In conclusion, the tumour infiltrating immune cells seem to be a major source of TP expression and predict a favourable prognosis in ER-negative breast cancer. Our data point to a role of TP in host immune response...
  11. ncbi Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Frankfurt, Germany
    Zentralbl Gynakol 128:76-81. 2006
    ..Furthermore we evaluated the predictive significance of prognostic gene signatures as described by Sorlie, van't Veer and Ahr for response to neoadjuvant chemotherapy...
  12. ncbi [Management of abnormal uterine bleeding]
    R Gaetje
    Klinik fur Gynakologie und Geburtshilfe, Johann Wolfgang Goethe Universitat, Frankfurt
    Zentralbl Gynakol 128:196-201. 2006
    ..The paper provides an overview of the various causes, useful diagnostic measures, and treatment options in uterine bleeding disorders...
  13. ncbi Mepivacaine for spinal anesthesia in parturients undergoing elective cesarean delivery: maternal and neonatal plasma concentrations and neonatal outcome
    D H Bremerich
    Klinik fur Anasthesiologie, Intensivmedizin und Schmerztherapie, Klinikum der Johannes Wolfgang Goethe Universität, Frankfurt am Main
    Zentralbl Gynakol 125:518-21. 2003
    ..However, advances in surgical technique and shorter duration of surgery make short-acting local anesthetic like mepivacaine appropriate, particularly if combined with opioids to enhance postoperative maternal pain relief...
  14. ncbi [Anesthetic regimen for HIV positive parturients undergoing elective cesarean section]
    D H Bremerich
    Klinik fur Anasthesiologie, Intensivmedizin und Schmerztherapie, Klinikum der Johann Wolfgang Goethe Universitat Frankfurt, Frankfurt
    Anaesthesist 52:1124-31. 2003
    ..The goal of the present study was to prospectively record perioperative maternal and neonatal complications in the largest HIV positive collective undergoing elective Cesarean section with spinal anesthesia published to date...
  15. ncbi [Integrin expression in eutopic and ectopic endometrium]
    R Gaetje
    Klinik fur Gynakologie und Geburtshilfe, Johann Wolfgang Goethe Universitat, Frankfurt
    Zentralbl Gynakol 128:135-7. 2006
    ..g., in the peritoneal fluid -- on the ectopic endometrium...
  16. ncbi [Disturbed utero-tubal transport in hysterosalpingoscintigraphy as a predictive functional test for IVF therapy]
    S Kissler
    Schwerpunkt für Gynäkologische Endokrinologie und Reproduktionsmedizin der Johann Wolfgang Goethe Universität, Franfurt am Main
    Zentralbl Gynakol 124:418-22. 2002
    ..Impaired transport function (negative HSSG) should be considered as an indication for IVF-treatment...
  17. ncbi [Isolated decrease of haptoglobin during pregnancy: diagnosis by chance or pathological? ]
    C Gatzka
    , Germany
    Zentralbl Gynakol 124:120-2. 2002
    ..Further studies need to focus on the differential diagnosis of a decrease of haptoglobin as well as an isolated decrease of haptoglobin during pregnancy and on the valid ranges of the different haptoglobin subtypes...